Jazz Pharmaceuticals JAZZ Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from Jazz Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's price / earnings?
- Jazz Pharmaceuticals (JAZZ) reported price / earnings of 15.6× in Q1 2025.
- How has Jazz Pharmaceuticals's price / earnings changed year-over-year?
- Jazz Pharmaceuticals's price / earnings decreased by 31.4% year-over-year, from 22.8× to 15.6×.
- What is the long-term trend for Jazz Pharmaceuticals's price / earnings?
- Over 2 years (2020 to 2024), Jazz Pharmaceuticals's price / earnings has grown at a -44.1% compound annual growth rate (CAGR), from 42.5× to 13.3×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.